This patient experienced some superior visual field loss following cataract surgery. A stagnant blob of triamcinolone-moxifloxacin accumulated in the subhyaloid space in the inferior macula.
The medication eventually dissolved as the patient’s symptoms resolved.
Learning Points:
TriMoxi is commonly used in dropless cataract surgery, so patients don’t need to use postoperative antibiotic and steroid drops. At the end of the procedure, 0.2cc of TriMoxi is injected into the anterior inferior vitreous. Usually, patients notice large black floaters that subside within a few weeks.
